Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Empagliflozin (10mg) Tablet
Therapeutic Category
Antidiabetic, Cardiovascular, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x10
Price
₹375/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Emplozin 10 Tablet is an antidiabetic medication that belongs to the class of Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors. It is designed to improve glycemic control in adults with type 2 diabetes mellitus when used alongside proper diet and exercise. Empagliflozin works by blocking glucose reabsorption in the kidneys, which leads to increased glucose excretion through urine, aiding in blood sugar regulation.
In addition to managing blood sugar levels, this medication has demonstrated cardiovascular benefits, including reducing the risk of hospitalization due to heart failure in patients with type 2 diabetes. Emplozin 10 Tablet is also beneficial in lowering blood pressure and contributing to weight management, making it an effective and comprehensive option for diabetes care.
This medication is particularly suited for patients seeking a modern solution to diabetes management that addresses both glycemic control and associated cardiovascular risks. It should be used under the supervision of a healthcare provider and as part of a holistic approach to diabetes care.
Common side effects include frequent urination, urinary tract infections, genital infections, and mild dehydration. Rare but serious side effects include diabetic ketoacidosis and severe genital infections.
Emplozin 10 Tablet is indicated for the management of type 2 diabetes mellitus as an adjunct to diet and exercise. It may also help reduce the risk of hospitalization for heart failure in patients with type 2 diabetes.
This medication is not intended for type 1 diabetes or diabetic ketoacidosis. Follow your doctor’s instructions and report any unusual symptoms promptly.
Store in a cool, dry place below 30°C. Protect from light and moisture. Keep out of reach of children.
Composition : Empagliflozin (25mg) Tablet
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
Composition : Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Empagliflozin 10mg Tablet is a widely prescribed anti-diabetic medicine used in type 2 diabetes management, making it a high-demand prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, blood sugar control, cardiovascular risk reduction support, weight management support, and long-term glycemic control. It is commonly prescribed by diabetologists and physicians as part of modern diabetes therapy.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Empagliflozin 10mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, growing diabetic patient populations, repeat monthly therapy usage, and high acceptance in diabetology and general medicine segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.